Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)
Source: SeekingAlpha
2026-02-07 00:20:44 ET
Introduction & Investment Thesis
In June 2025, I published a hold-rated article on Cardinal Health, Inc. ( CAH ) given its strong growth, which was marred by tariff uncertainties and increased costs affecting its profitability. Since that publication, the stock has gained more than 48%, beating the S&P 500 significantly, a testament to its resilience....
Read the full article on Seeking Alpha
For further details see:
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)
Cardinal Health Inc.
NASDAQ: CAH
CAH Trading
-0.13% G/L:
$219.08 Last:
449,370 Volume:
$221.13 Open:
CAH Latest News
February 24, 2026 07:00:00 am
Cardinal Health report highlights cost savings and provider confidence in biosimilars
February 21, 2026 06:32:27 pm
Beck Bode Initiates Churchill Downs Position as Regional Gaming Expansion Lifts Growth Prospects
CAH Stock Data
$52,060,138,800
232,962,856
N/A
726
N/A
Medical Distributors
Healthcare
US
Dublin
